Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis

BACKGROUND: The COVID-19 pandemic outbreak raises the question of whether immunization is recommended for patients with CNS demyelinating diseases. On the one hand, existing studies suggested that SARS-CoV-2 vaccinations are not associated with increased risk of relapse activity. On the other hand,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Lingyao, Wang, Xiaofei, Chen, Hongxi, Shi, Ziyan, Lang, Yanlin, Zhang, Ying, Zhou, Hongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472679/
https://www.ncbi.nlm.nih.gov/pubmed/36170773
http://dx.doi.org/10.1016/j.msard.2022.104167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472679/
https://www.ncbi.nlm.nih.gov/pubmed/36170773
http://dx.doi.org/10.1016/j.msard.2022.104167

Ejemplares similares